Eurosurv. Duration of SARS-CoV-2 RNA detection in COVID-19 patients in home isolation, Rhineland-Palatinate, Germany, 2020 – an interval-censored sur

[tetano]

• Duration of SARS-CoV-2 RNA detection in COVID-19 patients in home isolation, Rhineland-Palatinate, Germany, 2020 – an interval-censored survival analysis
  
  
• Sarah Omar[SUP]1[/SUP] , Christoph Bartz[SUP]2[/SUP] , Sabine Becker[SUP]2[/SUP] , Silke Basenach[SUP]3[/SUP] , Sandra Pfeifer[SUP]3[/SUP] , Corinna Trapp[SUP]4[/SUP] , Hildegard Hamm[SUP]5[/SUP] , Hans Christoph Schlichting[SUP]6[/SUP] , Magdalena Friederichs[SUP]7[/SUP] , Ulrich Koch[SUP]8[/SUP] , Christian Jestrabek[SUP]9[/SUP] , Ernst Hilger[SUP]10[/SUP] , Manfred Vogt[SUP]11[/SUP] , Klaus Jahn[SUP]12[/SUP] , Simiao Chen[SUP]13,14[/SUP] , Till B?rnighausen[SUP]13,15,16[/SUP] , Philipp Zanger[SUP]11,12,13,17[/SUP], on behalf of the Palatina Public Health Study Group[SUP]18[/SUP]

We analysed consecutive RT-qPCR results of 537 symptomatic coronavirus disease (COVID-19) patients in home quarantine. Respectively 2, 3, and 4 weeks after symptom onset, 50%, 25% and 10% of patients had detectable RNA from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In patients with mild COVID-19, RNA detection is likely to outlast currently known periods of infectiousness by far and fixed time periods seem more appropriate in determining the length of home isolation than laboratory-based approaches.

full article

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.30.2001292#abstract_content